Google
NBY — NOVABAY PHARMACEUTICALS INC (Healthcare >> Biotechnology)
NBY FAQ
What is NBY's P/E ratio?
NOVABAY PHARMACEUTICALS INC (NBY) currently trades at a P/E ratio of 0.09.
What is NBY's ROE?
NOVABAY PHARMACEUTICALS INC reports a Return on Equity (ROE) of 376.44%.
What is NBY's dividend yield?
NOVABAY PHARMACEUTICALS INC offers a dividend yield of 0.00%.
What is NBY's Deepscope Quality Score?
Deepscope rates NBY's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy NBY?
Deepscope's AI Timing Score for NBY is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does NBY belong to?
NOVABAY PHARMACEUTICALS INC is classified under the Healthcare >> Biotechnology sector on the NYSE MKT exchange.
|
USD 1.31
Price
-0.09
(-6.43%)
Day Change
|
|
|---|
NBY, ファンダメンタルスコアはok ( ファンダメンタル = 62) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
57% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 86 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.31 |
| PBV / Sector |
0.37 / 4.48
GREAT
|
| Earning Per Share | 13.19 |
| PE / Sector |
0.09 / 16.68
GREAT
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
0.19 M
GREAT
|
| Average 1W Daily Value |
0.31 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
37% |
| 登録情報 |
| Analyze Date | 2026-06-04 09:24:30 |
| Symbol | NBY |
| Name | NOVABAY PHARMACEUTICALS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NYSE MKT |
| Listed Shares | 26.63 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 51.92 / 8,483.11 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2000 Powell Street, Emeryville, CA, United States, 94608
Phone: 510 899 8800
Website: https://novabay.com
Sector: Healthcare >> Biotechnology
Description: NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
